Allogene Therapeutics Inc (ALLO)
2.77
-0.24
(-7.97%)
USD |
NASDAQ |
May 17, 16:00
2.77
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Accounts Payable (Quarterly): 5.779M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 5.779M |
December 31, 2023 | 5.897M |
September 30, 2023 | 6.205M |
June 30, 2023 | 10.23M |
March 31, 2023 | 14.69M |
December 31, 2022 | 13.89M |
September 30, 2022 | 11.04M |
June 30, 2022 | 9.713M |
March 31, 2022 | 8.708M |
December 31, 2021 | 10.26M |
September 30, 2021 | 11.50M |
June 30, 2021 | 11.00M |
Date | Value |
---|---|
March 31, 2021 | 14.88M |
December 31, 2020 | 10.39M |
September 30, 2020 | 10.15M |
June 30, 2020 | 9.057M |
March 31, 2020 | 7.199M |
December 31, 2019 | 9.25M |
September 30, 2019 | 8.047M |
June 30, 2019 | 23.50M |
March 31, 2019 | 12.98M |
December 31, 2018 | 12.34M |
September 30, 2018 | 3.083M |
June 30, 2018 | 1.268M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
5.779M
Minimum
Mar 2024
23.50M
Maximum
Jun 2019
10.57M
Average
10.19M
Median
Accounts Payable (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 49.43M |
Vaxart Inc | 3.978M |
Agenus Inc | 50.69M |
BioCryst Pharmaceuticals Inc | 11.91M |
Stereotaxis Inc | 3.307M |